Compare ANNX & OXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANNX | OXM |
|---|---|---|
| Founded | 2011 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 812.7M | 675.3M |
| IPO Year | 2020 | 1994 |
| Metric | ANNX | OXM |
|---|---|---|
| Price | $5.77 | $36.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $16.50 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 4.4M | 618.8K |
| Earning Date | 05-11-2026 | 06-10-2026 |
| Dividend Yield | N/A | ★ 6.80% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | N/A | ★ $1,477,834,000.00 |
| Revenue This Year | N/A | $2.85 |
| Revenue Next Year | $16,320.74 | $2.63 |
| P/E Ratio | ★ N/A | $36.99 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.03 | $30.57 |
| 52 Week High | $7.18 | $51.61 |
| Indicator | ANNX | OXM |
|---|---|---|
| Relative Strength Index (RSI) | 55.54 | 47.92 |
| Support Level | $4.75 | $34.86 |
| Resistance Level | $5.89 | $42.12 |
| Average True Range (ATR) | 0.42 | 1.91 |
| MACD | 0.08 | 0.31 |
| Stochastic Oscillator | 54.60 | 61.96 |
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company's business is organized as: Tommy Bahama, Lilly Pulitzer, Johnny Was and Emerging Brands reportable segments. Geographically, the company operates in United States as well as Internationally.